2-84670377-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001370.2(DNAH6):​c.6356A>G​(p.Tyr2119Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0241 in 1,543,308 control chromosomes in the GnomAD database, including 633 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.022 ( 50 hom., cov: 33)
Exomes 𝑓: 0.024 ( 583 hom. )

Consequence

DNAH6
NM_001370.2 missense

Scores

3
7
7

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 7.57

Publications

10 publications found
Variant links:
Genes affected
DNAH6 (HGNC:2951): (dynein axonemal heavy chain 6) This gene belongs to the dynein family, whose members encode large proteins that are constituents of the microtubule-associated motor protein complex. This complex is composed of dynein heavy, intermediate and light chains, which can be axonemal or cytoplasmic. This protein is an axonemal dynein heavy chain. It is involved in producing force for ciliary beating by using energy from ATP hydrolysis. Mutations in this gene may cause primary ciliary dyskinesia (PCD) as well as heterotaxy. [provided by RefSeq, Jun 2016]
DNAH6 Gene-Disease associations (from GenCC):
  • male infertility with azoospermia or oligozoospermia due to single gene mutation
    Inheritance: AR Classification: MODERATE Submitted by: King Faisal Specialist Hospital and Research Center

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0058374703).
BP6
Variant 2-84670377-A-G is Benign according to our data. Variant chr2-84670377-A-G is described in ClinVar as Benign. ClinVar VariationId is 402739.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.054 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAH6NM_001370.2 linkc.6356A>G p.Tyr2119Cys missense_variant Exon 39 of 77 ENST00000389394.8 NP_001361.1 Q9C0G6-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAH6ENST00000389394.8 linkc.6356A>G p.Tyr2119Cys missense_variant Exon 39 of 77 5 NM_001370.2 ENSP00000374045.3 Q9C0G6-1
DNAH6ENST00000602588.1 linkn.584A>G non_coding_transcript_exon_variant Exon 4 of 11 1

Frequencies

GnomAD3 genomes
AF:
0.0217
AC:
3303
AN:
152212
Hom.:
50
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0118
Gnomad AMI
AF:
0.0154
Gnomad AMR
AF:
0.0361
Gnomad ASJ
AF:
0.0446
Gnomad EAS
AF:
0.0106
Gnomad SAS
AF:
0.0594
Gnomad FIN
AF:
0.0102
Gnomad MID
AF:
0.101
Gnomad NFE
AF:
0.0226
Gnomad OTH
AF:
0.0354
GnomAD2 exomes
AF:
0.0269
AC:
4126
AN:
153544
AF XY:
0.0294
show subpopulations
Gnomad AFR exome
AF:
0.0103
Gnomad AMR exome
AF:
0.0262
Gnomad ASJ exome
AF:
0.0469
Gnomad EAS exome
AF:
0.00805
Gnomad FIN exome
AF:
0.00975
Gnomad NFE exome
AF:
0.0234
Gnomad OTH exome
AF:
0.0321
GnomAD4 exome
AF:
0.0244
AC:
33895
AN:
1390978
Hom.:
583
Cov.:
28
AF XY:
0.0260
AC XY:
17841
AN XY:
686070
show subpopulations
African (AFR)
AF:
0.0116
AC:
364
AN:
31336
American (AMR)
AF:
0.0270
AC:
952
AN:
35196
Ashkenazi Jewish (ASJ)
AF:
0.0480
AC:
1204
AN:
25070
East Asian (EAS)
AF:
0.0207
AC:
736
AN:
35586
South Asian (SAS)
AF:
0.0609
AC:
4739
AN:
77800
European-Finnish (FIN)
AF:
0.00867
AC:
427
AN:
49264
Middle Eastern (MID)
AF:
0.0696
AC:
395
AN:
5672
European-Non Finnish (NFE)
AF:
0.0218
AC:
23405
AN:
1073314
Other (OTH)
AF:
0.0290
AC:
1673
AN:
57740
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.449
Heterozygous variant carriers
0
1483
2966
4449
5932
7415
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
910
1820
2730
3640
4550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0217
AC:
3305
AN:
152330
Hom.:
50
Cov.:
33
AF XY:
0.0223
AC XY:
1660
AN XY:
74488
show subpopulations
African (AFR)
AF:
0.0118
AC:
490
AN:
41574
American (AMR)
AF:
0.0361
AC:
552
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0446
AC:
155
AN:
3472
East Asian (EAS)
AF:
0.0106
AC:
55
AN:
5188
South Asian (SAS)
AF:
0.0597
AC:
288
AN:
4824
European-Finnish (FIN)
AF:
0.0102
AC:
108
AN:
10626
Middle Eastern (MID)
AF:
0.0986
AC:
29
AN:
294
European-Non Finnish (NFE)
AF:
0.0226
AC:
1537
AN:
68022
Other (OTH)
AF:
0.0364
AC:
77
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
166
333
499
666
832
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
48
96
144
192
240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0234
Hom.:
155
Bravo
AF:
0.0218
TwinsUK
AF:
0.0232
AC:
86
ALSPAC
AF:
0.0195
AC:
75
ESP6500AA
AF:
0.00939
AC:
13
ESP6500EA
AF:
0.0236
AC:
75
ExAC
AF:
0.0338
AC:
827
Asia WGS
AF:
0.0390
AC:
134
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 09, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 29767709) -

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.18
T
BayesDel_noAF
Uncertain
0.020
CADD
Pathogenic
27
DANN
Uncertain
1.0
DEOGEN2
Benign
0.060
T;T
Eigen
Pathogenic
0.80
Eigen_PC
Pathogenic
0.74
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Uncertain
0.87
D;.
MetaRNN
Benign
0.0058
T;T
MetaSVM
Benign
-0.62
T
MutationAssessor
Uncertain
2.9
M;M
PhyloP100
7.6
PrimateAI
Uncertain
0.62
T
PROVEAN
Pathogenic
-6.0
D;D
REVEL
Uncertain
0.49
Sift
Benign
0.031
D;D
Polyphen
1.0
D;D
Vest4
0.34
MPC
0.20
ClinPred
0.019
T
GERP RS
5.1
Varity_R
0.30
gMVP
0.78
Mutation Taster
=45/55
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17025409; hg19: chr2-84897501; COSMIC: COSV107253846; API